Status:

COMPLETED

A Study of Baricitinib in Participants With Rheumatoid Arthritis

Lead Sponsor:

Eli Lilly and Company

Collaborating Sponsors:

Incyte Corporation

Conditions:

Rheumatoid Arthritis

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants ...

Eligibility Criteria

Inclusion

  • Participants must have at least one of the following characteristics:
  • Documented evidence of a VTE prior to this study
  • At least 60 years of age
  • A body mass index (BMI) greater than or equal to 30 kilograms per meter squared (kg/m²), or
  • Age 50 to less than 60 years and BMI 25 to less than 30 kg/m²
  • Participants must have an inadequate response or intolerance to at least 1 disease-modifying antirheumatic drugs (DMARD) (synthetic or biologic)

Exclusion

  • Participant must not have prior use of a Janus kinase (JAK) inhibitor or have received more than 1 prior TNF inhibitor that was:
  • discontinued for IR (lack or loss of efficacy) for RA, or
  • discontinued for intolerance (AE) when used for any indication
  • Participants must not be pregnant or breastfeeding
  • Participants must not have had more than one VTE
  • Participants must not have cancer
  • Participants must not have active herpes zoster, serious infection, active tuberculosis, or any other serious illness
  • Participants must not have had a live vaccine within four weeks of study start
  • Participants must not have participated in any other clinical trial within four weeks of study start
  • Participants must not have a history of IV drug use, other illicit drug abuse, or chronic alcohol abuse in the past year

Key Trial Info

Start Date :

February 14 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 19 2025

Estimated Enrollment :

1317 Patients enrolled

Trial Details

Trial ID

NCT04086745

Start Date

February 14 2020

End Date

May 19 2025

Last Update

July 17 2025

Active Locations (119)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 30 (119 locations)

1

Arizona Research Clinic PLLC

Chandler, Arizona, United States, 85225

2

Arizona Arthritis & Rheumatology Associates, P. C.

Mesa, Arizona, United States, 85202

3

Arizona Arthritis & Rheumatology Research

Paradise Valley, Arizona, United States, 85253

4

Sun Valley Arthritis Center, LTD

Peoria, Arizona, United States, 85381